2025 CCM Scientific Meeting - Virtual Attendance (International Only)

In consideration of the difficulty some international attendees may have in coming to the United States, this year, we are offering a virtual attendance option for international attendees only. You may submit an abstract for a hybrid plenary presentation or an unattended poster. The abstract submission deadline is July 7th.

We will provide a Zoom link closer to the time of the meeting.

The CCM Scientific Meeting is a venue for international stakeholders to assemble, share, and discuss the latest CCM research data. Alliance to Cure Cavernous Malformation hosts this annual meeting to facilitate scientific progress and collaborations.

Thursday, November 6th: A day of plenary sessions beginning at 8:30 am ET.
Friday, November 7th: A keynote speech at 9:00 am ET followed by a plenary session through 3:30 pm ET.

The early registration deadline is July 7th, 2025.

Who May Attend?

Attendance at the annual CCM Scientific Meeting is open for those with active CCM research programs (principal investigators, postdoctoral fellows, and students), clinical practice, drug development, and CCM advocacy (e.g., Alliance to Cure Cavernous Malformation Board members). Officials from the National Institutes of Health, the Food and Drug Administration, and international funding agencies are also encouraged to attend. Upon registration, attendees will complete an eligibility questionnaire. Final attendance eligibility determinations are subject to a decision by the Organizing Committee. To request a determination, please contact Connie Lee at clee@alliancetocure.org.

Attendance is limited to the above-described eligibility criteria to protect the confidentiality of unpublished data. Therefore, patients, care providers, and other family members (even those with medical or scientific training) cannot attend scientific sessions.

Thank you to our Sponsors!